Insider Trading Roundup: Kewaunee Scientific Corporation $KEQU

refugees-1020261_1920

Kewaunee Scientific Corporation (KEQU) insider have most recently took part in a trading activity. On Dec 27, 2017 Shaw Donald F., Director bought 2,000 shares having total worth of $57,580 at the price of $28.79 per share, following the transaction a total of 23,000 shares owned by Shaw Donald F.. Before this latest buy, Shaw Donald F. purchased KEQU at 1 other times during the past twelve months, for a total investment of $27,750 at an average of $27.75 per share.

Furthermore, over the past 12 months , the stock was traded 1 times by insiders. an employee of the company was the buyer in 1 instances.

Shares of Kewaunee Scientific Corporation (KEQU) traded up 1.42% on Jan 4, 2018, hitting $28.5. 1,854 shares of the company’s stock traded hands. Kewaunee Scientific Corporation has a 52 week low of $19.97 and a 52 week high of $31.2. The company’s market cap is $65 million.

Kewaunee Scientific Corporation (KEQU) last announced its earnings results on Dec 5, 2017. The company reported 0.62 earnings per share (EPS) for the quarter. The company had revenue of $41 million for the quarter During the same quarter in the previous year, the company posted 0.54 earnings per share. The company’s revenue for the quarter was up 14% on a year-over-year basis.

2017-12-05 2017-08-29 2017-06-20 2017-02-28 2016-12-06 2016-08-30 2016-06-21 2016-03-01 2015-12-08 2015-08-25
earnings per share 0.62 0.00 0.51 0.13 0.54 0.00 0.50 0.31 0.26 0.35
Revenue(M) 41.47 0 34.58 30.37 36.33 0 34.09 32.41 31.04 31.09

Kewaunee Scientific Corp. was founded in 1906, incorporated in Michigan in 1941, became publicly-held in 1968, and was reincorporated in Delaware in 1970. The Company is engaged is the design, manufacture, and installation of laboratory, healthcare, and technical furniture products. Laboratory furniture products include both steel and wood cabinetry, fume hoods, adaptable modular systems, moveable workstations, environmentally friendly casework, biological safety cabinets and epoxy resin counters and sinks. Healthcare furniture products include laminate casework, systems and related products for healthcare applications. Technical furniture products include column systems, slotted-post systems, pedestal systems and stand-alone benches. Its products are sold through purchase orders and contracts submitted by customers through its dealers and commissioned agents and a national distributor, as well as through competitive bids submitted by it and its subsidiaries in India and Singapore. Products are sold principally to pharmaceutical, biotechnology, industrial, chemical and commercial research laboratories, educational institutions, healthcare institutions, governmental entities, manufacturing facilities, and users of networking furniture. The raw materials and products manufactured by others and used by it in its products are cold-rolled carbon and stainless steel, hardwood lumber and plywood, paint, chemicals, resins, hardware, plumbing, and electrical fittings. Such materials and products are purchased from multiple suppliers and are typically readily available. The Company holds various patents and patent rights, but do not consider its success or growth is dependent upon its patents or patent rights. Products are sold to pharmaceutical, biotechnology, industrial, chemical and commercial research laboratories, educational institutions, healthcare institutions, governmental entities, manufacturing facilities and users of networking furniture. Its business is not dependent upon licenses, franchises, concessions, trademarks, royalty agreements, or labor contracts.

William White

William White is a financial writer. He graduated with a degree in Economics. He has contributed to major financial websites and print publications for over 8 years. He handles much of this site's news coverage for corporate insider activity, and occasionally cover other areas of financial sector.

About the Author

William White
William White is a financial writer. He graduated with a degree in Economics. He has contributed to major financial websites and print publications for over 8 years. He handles much of this site's news coverage for corporate insider activity, and occasionally cover other areas of financial sector.